Release date: 30 April 2019
Promoter – Financial IntermediaryDRAEGERWERK AG & CO KGAA
This project consists of research, development and innovation (RDI) investments related to medical technology.
This project concerns new product development, product improvements and product maintenance targeted for respiratory care, anaesthesia, thermoregulation, patient monitoring, clinical information technology (IT), workplace infrastructure and workplace and system functionality.
- Industry - Manufacturing
Proposed EIB finance (Approximate amount)
EUR 110 million
Total cost (Approximate amount)
EUR 277 million
Research and development (R&D) activities included in the project will not materially change current R&D practice and will be carried out within existing facilities already authorised for the same purpose and would therefore not require an Environmental Impact Assessment (EIA) under the Directive 2011/92/EU as amended.
The promoter is a private company not operating in the utilities sector and is thus not covered by EU Directives on procurement.
Signed - 4/04/2019
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).